title: Successful resection of mediastinal seminoma evaluated the response to induction chemotherapy with fluorodeoxyglucose-positron emission tomography.
abstract: Mediastinal seminoma is a rare malignant tumor, and the current strategy for primary mediastinal seminomas is making a prompt diagnosis and achieving an appropriate chemotherapy. However, consensus regarding the optimal post-chemotherapy management has not been reached. We experienced a case of 26-year-old man who was diagnosed mediastinal seminoma and evaluated the response to induction chemotherapy with fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT). Complete surgical excision of the tumor was performed. Pathologic findings of the surgical specimen showed no viable cells in the tumor.
authors: Division of Thoracic Surgery, Matsue Red Cross Hospital, Matsue, Shimane, Japan.
authors: Yasuto
authors: Y
authors: Sakaguchi
authors: Noritaka
authors: N
authors: Isowa
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D005047:Etoposide / Q000008:administration & dosage; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D008479:Mediastinal Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000601:surgery*; D064847:Multimodal Imaging; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D018239:Seminoma / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000601:surgery*; D014057:Tomography, X-Ray Computed
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D001761:Bleomycin; D005047:Etoposide; D002945:Cisplatin